In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
As of close of business last night, Enliven Therapeutics Inc’s stock clocked out at $25.30, down -2.69% from its previous closing price of $26.00. In other words, the price has decreased by -$2.69 from its previous closing price. On the day, 1.13 million shares were traded. ELVN stock price reached its highest trading level at $25.95 during the session, while it also had its lowest trading level at $24.98.
Ratios:
To gain a deeper understanding of ELVN’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 14.39 and its Current Ratio is at 14.39. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on September 09, 2024, initiated with a Buy rating and assigned the stock a target price of $37.
On June 11, 2024, Robert W. Baird started tracking the stock assigning a Outperform rating and target price of $32.
On April 09, 2024, Mizuho started tracking the stock assigning a Buy rating and target price of $34.Mizuho initiated its Buy rating on April 09, 2024, with a $34 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Sep 27 ’24 when Hohl Benjamin sold 4,250 shares for $24.27 per share. The transaction valued at 103,161 led to the insider holds 0 shares of the business.
Hohl Benjamin sold 2,000 shares of ELVN for $50,668 on Sep 30 ’24. The CHIEF FINANCIAL OFFICER now owns 0 shares after completing the transaction at $25.33 per share. On Oct 01 ’24, another insider, Hohl Benjamin, who serves as the Officer of the company, bought 12,009 shares for $25.54 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ELVN now has a Market Capitalization of 1223915264 and an Enterprise Value of 882880320.
Stock Price History:
Over the past 52 weeks, ELVN has reached a high of $27.67, while it has fallen to a 52-week low of $9.80. The 50-Day Moving Average of the stock is 8.96%, while the 200-Day Moving Average is calculated to be 29.21%.
Shares Statistics:
It appears that ELVN traded 221.27K shares on average per day over the past three months and 483800 shares per day over the past ten days. A total of 41.29M shares are outstanding, with a floating share count of 28.89M. Insiders hold about 38.84% of the company’s shares, while institutions hold 70.11% stake in the company. Shares short for ELVN as of 1726185600 were 5532400 with a Short Ratio of 25.00, compared to 1723680000 on 5320217. Therefore, it implies a Short% of Shares Outstanding of 5532400 and a Short% of Float of 28.98.
